ARCH Venture Partners XII, LLC - 10%+ Owner at Prime Medicine, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
PRME on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by ARCH Venture Partners XII, LLC since 11/29/2024

Holdings reported by ARCH Venture Partners XII, LLC for Prime Medicine, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6.23M $7.91M $1.27 Aug 1, 2025 By ARCH Venture Fund XII, L.P.
Common Stock 6.13M $7.78M $1.27 Aug 1, 2025 By ARCH Venture Fund X, L.P.
Common Stock 6.13M $7.78M $1.27 Aug 1, 2025 By ARCH Venture Fund X Overage, L.P.

Transactions reported by ARCH Venture Partners XII, LLC for Prime Medicine, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.